$ Value
$0
Shares
32,749
Price
$0
Filed
Mar 10
Insider
Name
SAYER KEVIN R
Title
Executive Chair
CIK
0001286858
Roles
Transaction Details
Transaction Date
2026-03-08
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
441,739
Footnotes
Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting on the one year anniversary of the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock. | Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person. | Included in this number are 106,972 unvested RSUs, 32,749 of which were granted on March 8, 2026 and shall vest on March 8, 2027, 56,993 of which were granted on March 8, 2025 and shall vest through March 8, 2028, and 17,230 of which were granted on March 8, 2024 and shall vest through March 8, 2027.
Filing Info
SAYER KEVIN R's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-08 | DXCM | A | $0 |
| 2026-03-08 | DXCM | F | $2.2M |
| 2026-01-29 | DXCM | A | $0 |
| 2026-01-29 | DXCM | F | $2.5M |
Other Insiders at DXCM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
SAYER KEVIN R
Executive Chair
|
— | — | 2026-03-08 |
|
Coleman Jon
EVP, Chief Commercial Officer
|
— | — | 2026-03-08 |
| Heller Bridgette P | — | $69K | 2026-02-12 |
|
Sylvain Jereme M
EVP, Chief Financal Officer
|
— | — | 2026-03-08 |
|
Leach Jacob Steven
President, CEO, and Director
|
— | — | 2026-03-08 |
|
Stern Sadie
EVP, Chief HR Officer
|
— | — | 2026-03-08 |
|
Brown Michael Jon
EVP, Chief Legal Officer
|
— | $217K | 2026-04-15 |
| Osterloh Albert Frederick IV | — | — | 2026-02-26 |